| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Coagulation factor X |
|---|
| Ligand | BDBM50262349 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_509609 (CHEMBL1001370) |
|---|
| IC50 | 1073±n/a nM |
|---|
| Citation |  O'Connor, SP; Atwal, K; Li, C; Liu, EC; Seiler, SM; Shi, M; Shi, Y; Stein, PD; Wang, Y Synthesis and evaluation of acylguanidine FXa inhibitors. Bioorg Med Chem Lett18:4696-9 (2008) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Coagulation factor X |
|---|
| Name: | Coagulation factor X |
|---|
| Synonyms: | Activated coagulation factor X (FXa) | Activated factor Xa heavy chain | Coagulation factor X precursor | Coagulation factor Xa | F10 | FA10_HUMAN | Factor X heavy chain | Factor X light chain | Factor Xa | Stuart factor | Stuart-Prower factor |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 54726.60 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | n/a |
|---|
| Residue: | 488 |
|---|
| Sequence: | MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEE
TCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKN
CELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR
KRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQE
CKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGE
AVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGI
VSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSG
GPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPE
VITSSPLK
|
|
|
|---|
| BDBM50262349 |
|---|
| n/a |
|---|
| Name | BDBM50262349 |
|---|
| Synonyms: | (S)-N-((m-toluidino)(2-oxo-1-(2-oxo-2-(pyrrolidin-1-yl)ethyl)azepan-3-ylamino)methylene)-1-benzoylpiperidine-4-carboxamide | CHEMBL506308 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C33H42N6O4 |
|---|
| Mol. Mass. | 586.7244 |
|---|
| SMILES | Cc1cccc(NC(NC(=O)C2CCN(CC2)C(=O)c2ccccc2)=N[C@H]2CCCCN(CC(=O)N3CCCC3)C2=O)c1 |r,w:7.6| |
|---|
| Structure | 
|
|---|
Search and Browse
